Chapter 550: Pharmaceutical Separation
Fortunately, Zhu Xiaojun and Wu Dongcheng both had foresight, and made corresponding changes when they realized that centralized management of clinical fees also had incomparable drawbacks. Pen? Interesting? Pavilion wWw. biquge。 info
At Zhu Xiaojun's suggestion, Wu Dongcheng used that money to set up a relief fund for poor patients.
However, all patients who are treated in cancer hospitals and meet the poverty requirements can apply to the hospital for fee reduction, and the amount of the reduction is paid by this fund.
At the same time, Zhu Xiaojun suggested that Wu Dongcheng greatly adjust the prices of drugs with clinical costs.
However, this suggestion was opposed by Wu Dongcheng.
From the perspective of pharmaceutical companies, cancer hospitals are only one of many customers, and if measured by sales, the cancer hospital market only accounts for one-thousandth or even less of their sales.
And if the cancer hospital exposes the lie of the emperor's new clothes, how will the pharmaceutical company react?
For pharmaceutical companies, the centralized management of clinical expenses in hospitals is already the bottom line they can accept, and if it goes too far, people will definitely not accept it.
It's a big deal to give up the market of cancer hospitals, lose some sales, and stop supplying drugs to cancer hospitals.
And a hospital that is short of this medicine and out of stock, really doesn't know how to run.
Just like the last theme pointed out by the appealing TV station in the program about drug rebates, the medical insurance bureau in a certain place has implemented reforms, squeezing out most of the water in drugs, and the average price of drug bidding has been reduced by more than 20 percent and nearly 30 percent, and the people have naturally benefited.
But is that really the case?
In an area where there is a shortage of medicines in the whole city, the people who are sick can only pay out of their own pockets to ask relatives and friends to buy medicine from other places to treat their diseases, and they really don't know how much benefit they get.
However, as an authority, those who only need to spend a little effort to cover up and cover one cover can be justified, and they will not delay themselves in gaining favor in front of higher-level leaders.
What is the root cause of this? When he was in Guangdong, Zhu Xiaojun had dinner and chatted with those academicians, and one of them hit the nail on the head.
The country is developing the pharmaceutical industry, because whether it is the national level or the local government, the pharmaceutical industry can always bring good GDP figures, and it can also collect a lot of taxes. Therefore, the top and bottom are turning a blind eye to the pharmaceutical industry, especially those state-owned pharmaceutical industries.
However, the vast majority of the products made by these domestic pharmaceutical companies are generic drugs, and they do not argue about the issue of intellectual property rights, but in terms of market competition, there are dozens of pharmaceutical factories in imitation of the same type of drugs, and over-the-counter drugs can also expand sales through advertising, while prescription drugs, which occupy most varieties, can only be operated through the mode of clinical promotion.
If you want to do a good job in clinical promotion, you must set the price of the drug at a price that is suitable for operation.
The so-called suitability is to refer to the price of the imported drug being imitated and position it at about 60% to 70% of its price.
No matter how high it is, it can't compete with imported drugs, and if it's low, it can't get a rebate ratio that can attract clinicians.
Under this system, in order to make domestic generic drugs have a better living space, then the best way is to raise the price of imported drugs.
Cycle after cycle, if the price of this medicine can be lowered, it will be strange!
Hospitals, especially public hospitals, are under the banner of non-profit medical institutions, and at most they do not receive subsidies from the state or localities, but they cannot collect a dime of taxes at the local level.
It's no good, then you have to carry the black pot.
Pity the managers of those hospitals, their appointment and dismissal are decided by the system, but the physique is pushing them out infinitely, not only do they have no power to speak, but if they go a little too far, they can be smashed down with countless big sticks. Therefore, the directors of various hospitals, except for those real celebrities, can only swallow their anger.
Wu Dongcheng has been the dean for many years, and these insiders are naturally very familiar, so he raised objections to Zhu Xiaojun's suggestion, and the price reduction of this medicine can only be within the range of the hospital's bonus ratio at most.
"Then increase the use of poverty funds, and at the same time adjust the fee structure of these patients who apply for funding, which can not only benefit poor patients, but also effectively subsidize the benefits of various clinical departments. After Zhu Xiaojun came to his senses, he adjusted his thoughts in a timely manner.
Wu Dongcheng still shook his head: "If you increase the intensity in this area and make the virtual into the real, then ...... We can't afford the pressure! If this news spreads, patients within a radius of hundreds of miles will come to see a doctor, and when the time comes, it will be difficult to say whether this bed is enough or not, not to mention the question of whether it is true or false! ”
This doesn't work, it doesn't work like that, it seems that only by following the trend and not making changes is the right thing, Zhu Xiaojun is out of options.
But after all, Wu Dongcheng is profound, and he came up with a countermeasure after a while: "We can take a bend to solve this contradiction, well, set up a pharmaceutical business company outside the hospital, and then split the pharmacy department of the hospital, part of it will be assigned to the drug business company, and the remaining part will stay in the hospital to do clinical services in a down-to-earth manner." ”
This proposal was highly appreciated by Zhu Xiaojun, and the profits could still be collected in his own pocket, but the shortcomings that were criticized by others were thrown away.
The only inconvenience is that the current pharmaceutical business license is not so easy to handle.
However, this problem is not a difficult problem within the resources of Wu Dongcheng, and it is a good choice to buy a shell or join forces with other pharmaceutical companies.
Wu Dongcheng is not a long-winded person, he thought of it and immediately began to implement, in one day, he negotiated the framework of cooperation with a private company engaged in drug business, and it took another day to split the pharmacy department of the hospital into two parts, and when the old man Meng called Zhu Xiaojun, Wu Dongcheng had already completed the arrangement of the structure in the tumor hospital, and the rest was just to find problems in the operation and make adjustments in time.
The world's martial arts, only fast is not broken.
Wu Dongcheng's quick knife slashed the numbness, and the defense value of the tumor hospital increased by at least ten times, and those who lost face in the 'loss of kidney' incident, even if they want to find fault at this moment, it is not so simple.